Keystone eSymposia Logo

Joint meeting with HIV Vaccines

HIV Pathogenesis and Cure

June 1-4, 2021 | Start Time TBD*
*Program is in development and subject to change



 Attention


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.


 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries


Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.


Apply Here


Human Immunodeficiency Virus type 1 (HIV) is the cause of a global pandemic that has a very high mortality rate, with an estimated 35 million deaths to date. In addition, another 37 million people are currently living with HIV infection and will likely succumb from acquired immune deficiency syndrome (AIDS) without lifelong antiretroviral therapy (ART). Optimal ART can halt viral replication, thereby preventing disease progression and allowing immune reconstitution. However, ART is not curative due the persistence of a latent form of the virus. This latent form is the major barrier to cure and the subject of an intense international research effort. Along with efforts to develop an HIV vaccine, targeting the HIV latent reservoir is a major priority for AIDS research. Achieving a better understanding of the basic biology of HIV infection is likely to be essential to HIV cure efforts. 

This conference will bring together scientists studying basic aspects of HIV virology as well as investigators working directly on the cure problem. Immune-based strategies to eliminate infected cells are an important component of many cure strategies, providing a logical connection to hold the joint conference on HIV Vaccines. This pairing will provide a unique opportunity to bring together basic and translational immunologists and virologists to consider the challenging goal of curing HIV infection. In addition to joint sessions focusing on exciting new developments in the study of antibody and T cell responses to HIV and novel technologies that will aid future studies of HIV biology, sessions also include basic mechanisms of HIV integration and transcriptional control, strategies for reversing latency and eliminating infected cells, and trials of novel cure strategies in animal models and in patients on ART. The goal of this conference is to bring together an amalgamation of basic and applied scientists working on functional cures and eradication of HIV in an effort to not only better understand HIV treatment strategies but also the emerging technologies and approaches that will lead to the eventual eradication of HIV from infected individuals.

Apply Here for Free On Demand Access

Pricing:

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

Deadlines:

Abstract Submission
‣ For Short Talk Consideration: April 20, 2021
‣ For ePoster Presentation: May 18, 2021
Final ePoster / SciTalk Submission: May 21, 2021
Financial Aid Application: May 18, 2021

*Abstract submission is required in order to submit an ePoster and/or Scitalk

#VKSHIVPath21


Financial Aid Opportunities

Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine-related fields, are eligible to apply for a FREE registration code.

Find out more about financial aid opportunities here!


Call For Abstracts

Showcase your work to global audiences on the eSymposia platform!

Submit your abstract by the Short Talk Deadline for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program!

ePoster presenters will be provided with their own dedicated abstract listing on the event website to display their work in multiple formats, and interact with meeting participants. ePoster features include:

  • Abstract Description
  • An embedded ePoster with an optional downloadable PDF
  • SciTalk – up to 5-minute video presentation, available on demand
  • A poster table at the Live Poster Session to present your work and answer audience questions in real-time
  • A chat function to speak with interested attendees and answer questions throughout the conference
  • Contact information for private follow-up discussion

To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.



Program Details



Keynote Speaker


[Pedro L. Alonso, MD, PhD]

[Pedro L. Alonso, MD, PhD]
[World Health Organization, Director of the Global Malaria Programme]


Speaking at this eSymposia


Julie Ake

Walter Reed Army Institute of Research, USA


Petronela Ancuta

Centre de Recherche de l'Universite de Montreal, Canada


Dan H. Barouch

Beth Israel Deaconess Medical Center, USA


Paula M. Cannon

University of Southern California, Keck School of Medicine, USA


Angela Ciuffi

Institute of Microbiology - CHUV/UNIL, Switzerland


Bryan R. Cullen

Duke University Medical Center, USA


Steven G. Deeks

University of California, San Francisco, USA


Barbara K. Felber

NCI, National Institutes of Health, USA


Guillaume J. Filion

Centre of Genomic Regulation, Spain


Beatrice H. Hahn

University of Pennsylvania, USA


Reuben S. Harris

University of Minnesota, USA


Brad Jones

Weill Cornell Medicine, USA


Frank Kirchhoff

University of Ulm, Germany


Sharon R. Lewin

University of Melbourne, Australia


Jeremy Luban

University of Massachusetts Medical School, USA


Marina Lusic

University Clinic Heidelberg, Germany


M. Juliana McElrath

Fred Hutchinson Cancer Research Center, USA


Beatriz Mothe

IrsiCaixa AIDS Research Institute-HIVACAT, Spain


Afam Okoye

Oregon Health & Science University , USA


Melanie M. Ott

Gladstone Institutes, USA


Rafick Sekaly

Emory University, USA


Devi SenGupta

Gilead Sciences, Inc., USA


Liang Shan

Washington University in St. Louis, USA


Robert F. Siliciano

Johns Hopkins University School of Medicine, USA


Carine M. Van Lint

University of Brussels, Belgium


Xu Yu

Massachusetts General Hospital, USA


Jerome A. Zack

University of California, Los Angeles, USA






Sponsors


 

sponsor-carousel-cellpress.png

 




Additional Support



sponsor-carousel-bmgf.png

sponsor-carousel-nci.png

sponsor-carousel-novus.png

Funding for this conference was made possible (in part) by Grant No. [GRANT NUMBER - UPDATE] from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media-in-Kind Support


sponsor-carousel-cellpress.png

sponsor-carousel-jcb-jem.png

sponsor-carousel-embo.png

sponsor-carousel-frontiers.png

Sponsor-Carousel-Leibert-Publishing.png

Sponsor-Carousel-nature-portfolio.png

 

sponsor-carousel-scientist.png

 





The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






#ScienceMustGoOn



This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community.  Here, Debbie Johnson, our CEO, explains how we're going to do that.




Donate to Keystone Symposia


Donate to Keystone Symposia



Tags: